FDA Approves Senseonics’ Continuous Glucose Monitoring System
Senseonics announces the approval of its next-generation Eversense E3 CGM System by the U.S. FDA.
Read MoreFeb 16, 2022 | FDA Updates, Remote Monitoring | 0 |
Senseonics announces the approval of its next-generation Eversense E3 CGM System by the U.S. FDA.
Read MoreJan 28, 2022 | Patient Care Equipment | 0 |
Insulet received clearance from the FDA for its Omnipod 5 Automated Insulin Delivery System for individuals with type 1 diabetes.
Read MoreJan 24, 2022 | Company News | 0 |
IBM Watson Health is selling off its healthcare data and analytics assets to a private equity firm, only a month after the unit debuted new artificial intelligence-based imaging technology.
Read MoreDec 16, 2021 | Patient Care Equipment | 0 |
Children’s Hospital Los Angeles developed a new insulin calculator to reduce the need for one-off orders of insulin doses for inpatients with diabetes.
Read MoreDec 15, 2021 | Patient Care Equipment, Recalls | 0 |
The warning letter from the FDA is related to recalls of the MiniMed 600 series insulin infusion pump, and a device for MiniMed 508 and Paradigm pumps.
Read More